Dublin, Jan. 26, 2017 -- Research and Markets has announced the addition of the "Coagulation/Hemostasis Analyzer Market - Forecast to 2021" report to their offering.
The coagulation analyzer market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021.
Based on end-users, the coagulation analyzers market are classified into clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Increasing prevalence of CVD's and the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories will drive the growth of this market.
Geographically, the coagulation analyzers market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population and increasing prevalence of CVD's.
The major factors contributing to the growth of the coagulation analyzers market include increasing high incidences of CVD's, increasing blood related disorders, and rising geriatric population. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies and high cost of fully automated hemostasis analyzers are the major factors restraining the growth of this market. The high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market.
The major players in this market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).
Companies Mentioned:
- Alere Inc.
- Diagnostica Stago Sas
- Helena Laboratories
- Instrumentation Laboratory (A Division of the Werfen Group)
- International Technidyne Corporation (ITC)
- Nihon Kohden Corporation
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
- Siemens Healthcare (A Division of Siemens AG)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Coagulation Analyzer Market, By Product
7 Coagulation Analyzer Market, By Test
8 Coagulation Analyzer Market, By Technology
9 Coagulation Analyzer Market, By Patient Care Setting
10 Coagulation Analyzer Market, By Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/8r28q4/coagulationhemost
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices, Coagulation and Hemostasis Testing


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Apple Turns 50: From Garage Startup to AI Crossroads 



